(Press-News.org) Contact information: Julie Langelier
julie.langelier@ircm.qc.ca
514-987-5555
Institut de recherches cliniques de Montreal
The importance of standardizing drug screening studies
An IRCM researcher sheds light on inconsistencies between large pharmacogenomic studies
Montréal, December 2, 2013 – A bioinformatics expert at the IRCM, Benjamin Haibe-Kains, recently published an article stressing the importance of standardizing drug screening studies in the prestigious scientific journal Nature. The study supports the need for further development and standardization to improve the reproducibility of drug screening studies, as they are important in identifying new therapeutic agents and their potential combinations with existing drugs.
Dr. Haibe-Kains's article investigated results from two large-scale pharmacogenomic studies – the Cancer Genome Project (CGP) and the Cancer Cell Line Encyclopedia (CCLE) – published last year in Nature. The main goal of these studies was to identify genomic biomarkers that could predict patients' response to anticancer drugs. Because cancer patients often exhibit varied responses to anticancer treatments, and evidence indicates that response is determined in part by patient-specific genome alterations, cancer cell line studies have long been used to test the efficacy of therapeutic agents and explore genomic factors associated with drug response. These two studies screened multiple new and approved drugs on nearly 1,000 panels of cancer cell lines, of which 15 drugs and 471 cell lines were common.
"These studies provided us with a unique opportunity to look at the reproducibility of biomarker discovery in preclinical settings," says Dr. Haibe-Kains, Director of the Bioinformatics and Computational Biology research unit at the IRCM. "Our objective was to examine the uniformities and inconsistencies between results from the two independent studies, and assess the potential of building predictive models of drug response on the basis of those results."
Dr. Haibe-Kains and his research team observed overall good consistency of genomic profiles, which contain information about all the genes in the body and can be used to determine response to a drug. However, drug sensitivity measurements used in the two studies were highly inconsistent.
"We believe the reasons for such differences include the lack of standardization in experimental assays and data analysis methods," adds Dr. Haibe-Kains. "For example, the studies tested different drug concentrations and used different statistical models to analyze their data. In addition, due to discrepancies in drug sensitivity data, some potential biomarkers were inconsistent between the two studies."
"These pharmacogenomic studies are generally the first step in a larger experimental pipeline where candidate drugs and biomarkers are further validated in animal studies and human clinical trials," explains Dr. Haibe-Kains. "Our findings support the need for standardization of drug-response measurements or the development of new, robust drug sensitivity assays in order to identify reliable genomic predictors of drug response or effectively identify a drug's mechanism of action."
"It is important to note that our study and the resulting observations could not have been possible if the data had not been well documented and made accessible to the scientific community," concludes Dr. Haibe-Kains. "This represents a big success for open data science and reproducible research, and we would like to thank the investigators from the CGP and CCLE studies who made their invaluable data available to researchers everywhere. Without this data, we would not have been able to discover the discrepancies. We now need to work together to improve the reproducibility of large-scale screening studies so that we can identify new therapeutic agents and their potential combinations with existing drugs."
###
The study was conducted in collaboration with Nehme El-Hachem from the IRCM, and researchers from the Technical University of Denmark and the Dana Farber Cancer Institute in Boston.
For more information, please refer to the article summary published online by Nature: http://www.nature.com/nature/journal/vaop/ncurrent/full/nature12831.html#access.
About the IRCM
Founded in 1967, the Institut de recherches cliniques de Montréal is currently comprised of 36 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses four specialized research clinics, eight core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University. The IRCM is funded by the Quebec ministry of Higher Education, Research, Science and Technology.
The importance of standardizing drug screening studies
An IRCM researcher sheds light on inconsistencies between large pharmacogenomic studies
2013-12-02
ELSE PRESS RELEASES FROM THIS DATE:
Nanorobot for transporting drugs in the body
2013-12-02
Nanorobot for transporting drugs in the body
A nanorobot is a popular term for molecules with a unique property that enables them to be programmed to carry out a specific task. In collaboration with colleagues in Italy and the USA, researchers at Aarhus University have ...
New report illustrates persistent global burden of anemia among high-risk populations
2013-12-02
New report illustrates persistent global burden of anemia among high-risk populations
(WASHINGTON, December 2, 2013) – Despite increasing efforts to diagnose and treat anemia worldwide, there remains a surprisingly large global burden of the disease, particularly ...
Researchers unlock a new means of growing intestinal stem cells
2013-12-02
Researchers unlock a new means of growing intestinal stem cells
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes
CAMBRIDGE, MA -- Researchers at MIT and Brigham and Women's Hospital have shown ...
Mice can inherit learned sensitivity to a smell
2013-12-02
Mice can inherit learned sensitivity to a smell
Trauma can scar people so indelibly that their children are affected. History provides examples of generations traumatized by war and starvation, whose children experience altered physiology.
Now researchers at Yerkes ...
Forget the needle consider the haystack
2013-12-02
Forget the needle consider the haystack
Uncovering hidden structures in massive data collections
Advances in computer storage have created collections of data so huge that researchers often have trouble uncovering critical patterns in connections ...
Living with chronic pain: The daily struggle with a 'new self'
2013-12-02
Living with chronic pain: The daily struggle with a 'new self'
People who suffer with chronic musculoskeletal pain face a daily struggle with their sense of self and find it difficult to prove the legitimacy of their condition.
A new study, funded by the National Institute ...
Oxygen levels increase and decrease the effectiveness of anti-inflammatory therapies
2013-12-02
Oxygen levels increase and decrease the effectiveness of anti-inflammatory therapies
New research published in the Journal of Leukocyte Biology suggests that the effectiveness of anti-inflammatory glucocorticoids may be related to ...
Understanding hearing
2013-12-02
Understanding hearing
Computer models of neuronal sound processing in the brain lead to cochlear implant improvements
This news release is available in German.
Intact hearing is a prerequisite for learning to speak. This is why children ...
Newly discovered human peptide may become a new treatment for diabetes
2013-12-02
Newly discovered human peptide may become a new treatment for diabetes
New research in The FASEB Journal suggests that humanin, a peptide produced by the human body, increases the metabolism of glucose in beta cells, which in turn ...
Salk scientists crack riddle of important drug target
2013-12-02
Salk scientists crack riddle of important drug target
New method for determining structure of key cellular receptors could speed drug development
LA JOLLA, CA---- A new approach to mapping how proteins interact with each other, developed at the Salk Institute for Biological Studies, ...
LAST 30 PRESS RELEASES:
Antidepressant shows promise for treating brain tumors
European Green Deal: a double-edged sword for global emissions
Walking in lockstep
New blood test could be an early warning for child diabetes
Oceanic life found to be thriving thanks to Saharan dust blown from thousands of kilometers away
Analysis sheds light on COVID-19-associated disease in Japan
Cooler heads prevail: New research reveals best way to prevent dogs from overheating
UC Riverside medical school develops new curriculum to address substance use crisis
Food fussiness a largely genetic trait from toddlerhood to adolescence
Celebrating a century of scholarship: Isis examines the HSS at 100
Key biomarkers identified for predicting disability progression in multiple sclerosis
Study: AI could lead to inconsistent outcomes in home surveillance
Study: Networks of Beliefs theory integrates internal & external dynamics
Vegans’ intake of protein and essential amino acids is adequate but ultra-processed products are also needed
Major $21 million Australian philanthropic investment to bring future science into disease diagnosis
Innovating alloy production: A single step from ores to sustainable metals
New combination treatment brings hope to patients with advanced bladder cancer
Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston
UTIA researchers win grant for automation technology for nursery industry
Can captive tigers be part of the effort to save wild populations?
The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program
Mysteries of the bizarre ‘pseudogap’ in quantum physics finally untangled
Study: Proteins in tooth enamel offer window into human wellness
New cancer cachexia treatment boosts weight gain and patient activity
Rensselaer researcher receives $3 million grant to explore gut health
Elam named as a Fellow of the Electrochemical Society
Study reveals gaps in access to long-term contraceptive supplies
Shining a light on the roots of plant “intelligence”
Scientists identify a unique combination of bacterial strains that could treat antibiotic-resistant gut infections
Pushing kidney-stone fragments reduces stones’ recurrence
[Press-News.org] The importance of standardizing drug screening studiesAn IRCM researcher sheds light on inconsistencies between large pharmacogenomic studies